查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1750726

北美注射輸液幫浦市場規模、佔有率、趨勢分析報告：按適應症、最終用途、國家和細分市場預測，2025 年至 2030 年

North America Syringe Infusion Pumps Market Size, Share & Trends Analysis Report By Disease Indication (Pediatrics/neonatology, Chemotherapy, Diabetes, Gastroenterology), By End Use (Hospitals, Homecare), By Country, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

北美注射輸液幫浦市場的成長與趨勢：

根據 Grand View Research, Inc. 的一份新報告，北美注射輸液幫浦市場預計到 2030 年將達到 10.4 億美元，2025 年至 2030 年的複合年成長率為 8.4%。

預計市場將經歷顯著成長，主要原因是慢性病盛行率不斷上升（影響約六成美國成年人），以及對癌症和糖尿病等疾病進行精確和持續藥物劑量治療的需求。

外科手術和重症監護室（ICU）入院人數的增加，對幫浦的需求也隨之增加，而幫浦對於麻醉劑和重症監護藥物的給藥至關重要。考慮到美國住院人數預計將從2025年的3,600萬人增加到2035年的4,000萬人，這種情況尤其明顯。

智慧輸液技術的進步，包括配藥錯誤減少系統 (DERS) 以及與電子健康記錄的兼容性，對於提高用藥安全性和效率至關重要，北美在該領域的應用處於領先地位。受人口老化和成本控制策略的推動，家庭醫療保健和門診護理行業不斷擴張，推動了對攜帶式、易於使用的注射式幫浦的需求，以便在醫院外安全地進行藥物管理。良好的法規環境和報銷政策進一步推動了市場的持續成長和技術創新。

北美注射器輸液幫浦市場報告重點

  • 預計到 2024 年，小兒科/新生兒科將佔據最大的收入佔有率，超過 25.0%。這是因為新生兒和嬰兒迫切需要精確的藥物輸送，同時安全技術的進步和對 NICU/PICU 的投資。
  • 預計在預測期內，化療部分將以最快的複合年成長率成長。
  • 市場成長的動力來自於對採用精確注射式幫浦輸送強效藥物的迫切需求以及安全措施的支持，以及癌症患者數量的不斷增加。
  • 由於重症加護和多樣化應用對精準藥物傳遞的需求很高，預計醫院將主導市場，佔 2024 年總收入佔有率的約 40.0%。
  • 預計預測期內家庭護理將以 8.7% 的最快複合年成長率成長。
  • 由於慢性病發病率高和全國醫療保健成本上升，美國在北美注射輸液幫浦市場佔據主導地位。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章北美注射輸液幫浦市場變數、趨勢與範圍

  • 市場展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 北美注射輸液幫浦市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章北美注射輸液幫浦市場：依疾病類型估計與趨勢分析

  • 疾病適應症細分儀表板
  • 北美注射輸液幫浦市場：疾病適應症變化分析
  • 北美注射輸液幫浦市場規模及趨勢分析（依疾病，2018-2030）
  • 化療
  • 糖尿病
  • 胃腸病學
  • 鎮痛/疼痛管理
  • 小兒科/新生兒科
  • 血液學
  • 其他

5. 北美注射輸液幫浦市場：依最終用途的估計與趨勢分析

  • 最終用途細分儀表板
  • 北美注射輸液幫浦市場：最終用途差異分析
  • 2018-2030年北美注射輸液幫浦市場規模及趨勢分析（依最終用途）
  • 醫院
  • 居家護理
  • 其他（ASC、療養院、復健中心）

第6章北美注射輸液幫浦市場：按國家/地區進行的估計和趨勢分析

  • 各國市場儀表板
  • 2024 年及 2030 年各國市場
  • 北美注射輸液幫浦市場（按國家/地區）關鍵要點
  • 美國
    • 主要國家趨勢
    • 法規結構/報銷結構
    • 競爭場景
  • 加拿大
    • 主要國家趨勢
    • 法規結構/報銷結構
    • 競爭場景
  • 墨西哥
    • 主要國家趨勢
    • 法規結構/報銷結構
    • 競爭場景

第7章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 2024年主要企業熱圖分析
  • 公司簡介
    • Baxter
    • B. Braun Medical Inc.
    • Fresenius Kabi AG
    • ICU Medical, Inc.
    • Micrel Medical Devices SA
    • Boston Scientific Corporation
    • BD
    • Terumo Corporation
    • Moog Inc.
    • IRadimed Corporation
    • CODAN Companies
    • ACROMED
Product Code: GVR-4-68040-567-1

North America Syringe Infusion Pumps Market Growth and Trends:

The North America syringe infusion pumps market size is anticipated to reach USD 1.04 billion by 2030 and is expected to grow at a CAGR of 8.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing substantial growth driven by the increasing prevalence of chronic diseases, affecting approximately six in ten adults and necessitating precise, continuous medication delivery for conditions such as cancer and diabetes.

The rising number of surgical procedures and ICU admissions further amplifies demand for these pumps, crucial for delivering anesthetics and critical care medications. This is especially true considering the projected increase in U.S. hospitalizations from 36 million in 2025 to 40 million by 2035.

Technological advancements in smart infusion technologies, including Dose Error Reduction Systems (DERS) and EHR compatibility, are pivotal in enhancing medication safety and efficiency, as North America leads in their adoption. The expanding home healthcare and ambulatory care sectors, fueled by an aging population and cost-containment strategies, are increasing the demand for portable, user-friendly syringe pumps for safe medication delivery outside hospitals. Favorable regulatory environments and reimbursement policies further support the sustained growth and innovation within the market.

North America Syringe Infusion Pumps Market Report Highlights:

  • Pediatrics/neonatology held the largest revenue share of over 25.0% in 2024, owing to the critical need for precise drug delivery for newborns and infants, coupled with advancements in safety technologies and NICU/PICU investments
  • The chemotherapy segment is projected to grow at the fastest CAGR over the forecast period
  • Market growth is fueled by the critical need for precise syringe pump delivery of potent drugs, supported by safety features, and the increasing number of cancer cases.
  • Hospitals dominated the market with around 40.0% of the total revenue share in 2024 due to high demand for precise drug delivery in critical care and diverse applications.
  • Homecare is projected to grow at the fastest CAGR of 8.7% over the forecast period.
  • The U.S. dominated the North American syringe infusion pumps market, supported by the high prevalence of chronic diseases and growing national healthcare expenditure.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Disease Indication
    • 1.2.2. End Use
    • 1.2.3. Country scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Disease indication outlook
    • 2.2.2. End use outlook
    • 2.2.3. Country outlook
  • 2.3. Competitive Insights

Chapter 3. North America Syringe Infusion Pumps Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. North America Syringe Infusion Pumps Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. North America Syringe Infusion Pumps Market: Disease Indication Estimates & Trend Analysis

  • 4.1. Disease Indication Segment Dashboard
  • 4.2. North America Syringe Infusion Pumps Market: Disease Indication Movement Analysis
  • 4.3. North America Syringe Infusion Pumps Market Size & Trend Analysis, by Disease Indication, 2018 to 2030 (USD Million)
  • 4.4. Chemotherapy
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Diabetes
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Gastroenterology
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Analgesia/Pain Management
    • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Pediatrics/Neonatology
    • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.9. Hematology
    • 4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10. Others
    • 4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. North America Syringe Infusion Pumps Market: End Use Estimates & Trend Analysis

  • 5.1. End Use Segment Dashboard
  • 5.2. North America Syringe Infusion Pumps Market: End Use Movement Analysis
  • 5.3. North America Syringe Infusion Pumps Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Homecare
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Others (ASC, Nursing Homes, Rehabilitation Centers)
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. North America Syringe Infusion Pumps Market: Country Estimates & Trend Analysis

  • 6.1. Country Market Dashboard
  • 6.2. Country Market Share Analysis, 2024 & 2030
  • 6.3. North America Syringe Infusion Pumps Market by country: Key Takeaways
  • 6.4. U.S.
    • 6.4.1. Key country dynamics
    • 6.4.2. Regulatory framework/ reimbursement structure
    • 6.4.3. Competitive scenario
    • 6.4.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Canada
    • 6.5.1. Key country dynamics
    • 6.5.2. Regulatory framework/ reimbursement structure
    • 6.5.3. Competitive scenario
    • 6.5.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Mexico
    • 6.6.1. Key country dynamics
    • 6.6.2. Regulatory framework/ reimbursement structure
    • 6.6.3. Competitive scenario
    • 6.6.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company heat map analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Baxter
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. B. Braun Medical Inc.
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Fresenius Kabi AG
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. ICU Medical, Inc.
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Micrel Medical Devices SA
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Boston Scientific Corporation
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. BD
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Terumo Corporation
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Moog Inc.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. IRadimed Corporation
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. CODAN Companies
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. ACROMED
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Product benchmarking
      • 7.4.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America syringe infusion pumps market, by country, 2018 - 2030 (USD Million)
  • Table 3 North America syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 4 North America syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 5 U.S. syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 6 U.S. syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 8 Canada syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Mexico syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 10 Mexico surgical ablation market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 North America syringe infusion pumps market: market outlook
  • Fig. 10 North America syringe infusion pumps competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 North America syringe infusion pumps market driver impact
  • Fig. 16 North America syringe infusion pumps market restraint impact
  • Fig. 17 North America syringe infusion pumps market strategic initiatives analysis
  • Fig. 18 North America syringe infusion pumps market: Disease indication movement analysis
  • Fig. 19 North America syringe infusion pumps market: Disease indication outlook and key takeaways
  • Fig. 20 Chemotherapy estimates and forecast, 2018 - 2030
  • Fig. 21 Diabetes estimates and forecast, 2018 - 2030
  • Fig. 22 Gastroenterology estimates and forecast, 2018 - 2030
  • Fig. 23 Analgesia/Pain management estimates and forecast, 2018 - 2030
  • Fig. 24 Pediatrics/Neonatology estimates and forecast, 2018 - 2030
  • Fig. 25 Hematology estimates and forecast, 2018 - 2030
  • Fig. 26 Others estimates and forecast, 2018 - 2030
  • Fig. 27 North America syringe infusion pumps market: End use movement analysis
  • Fig. 28 North America syringe infusion pumps market: End use outlook and key takeaways
  • Fig. 29 Hospitals estimates and forecast, 2018 - 2030
  • Fig. 30 Homecare estimates and forecast, 2018 - 2030
  • Fig. 31 Others (ASC, nursing homes, rehabilitation centers) estimates and forecast, 2018 - 2030
  • Fig. 32 North America syringe infusion pumps market: Country movement analysis
  • Fig. 33 North America syringe infusion pumps market: Country outlook and key takeaways
  • Fig. 34 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 35 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 36 Mexico market estimates and forecasts, 2018 - 2030